Purchase Order 75N92019P00107

The National Heart, Lung and Blood Institute awarded a $24,000 purchase order contract to Genomic Testing Cooperative, LCA, a small disadvantaged business located in Lake Forest, California, for hematology panel sequencing and somatic mutation analysis services. The contract, which commenced on December 22, 2025 and extends through December 21, 2026, requires the contractor to conduct next-generation sequencing of bone marrow samples to identify somatic mutations that will provide guidance for...

The Department of Veterans Affairs, Veterans Integrated Service Network 10 (VISN 10) awarded a $243.75K firm fixed-price purchase order to Adaptive Biotechnologies Corporation for ClonoSEQ testing services, with a completion date of December 28, 2026. The contract, awarded on December 29, 2025, supports molecular diagnostic testing at the Cleveland, OH location. ClonoSEQ is a minimal residual disease testing service that uses advanced immunosequencing technology to detect cancer cells...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed price purchase order to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., to provide Next Generation Sequencing (NGS) reagents. The $169,560 contract is to support genomic analysis and testing for personalized medicine research at the NIH Clinical Center. Caredx Lab Solutions has previously provided NGS reagent kits and other organ transplant testing products and services to...

The National Heart, Lung and Blood Institute (NHLBI) awarded a $24,000 firm fixed-price purchase order to Genomic Testing Cooperative, LCA, a small disadvantaged business based in Lake Forest, California, on January 20, 2026. The contract, which has no set-aside designation, requires the contractor to perform hematology panel sequencing on bone marrow samples to identify somatic mutations for the NHLBI's Young Lab. The resulting genetic analysis provides critical guidance for disease diagnosis...

This is a firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to Neogenomics Laboratories, Inc., a for-profit cancer diagnostics laboratory based in Fort Myers, Florida. The $24,614 contract is for the provision of human genomics testing services to support the diagnosis and assessment of hematological disorders and malignancies for the NHLBI's Hematology Branch/Wiestner...

The Defense Health Agency awarded Adaptive Biotechnologies Corporation a firm fixed-price purchase order valued at $224,250 for FDA-cleared ClonoSEQ in vitro diagnostic testing services to detect blood cancer in patients. The contract, awarded on February 28, 2025, is scheduled for completion by February 27, 2030, and will be performed at the Defense Health Agency's Bethesda, Maryland location. This procurement was conducted through open competition with no set-aside designation. Adaptive...

The National Institutes of Health Clinical Center awarded a $292,972.80 firm fixed-price purchase order to CareDx Lab Solutions Inc. for AlloSeq TX17 Next Generation Sequencing (NGS) reagent kits, with an ultimate completion date of September 30, 2026. The contract, which carries no set-aside designation, represents a continuation of the agency's relationship with CareDx Lab Solutions, a West Chester, Pennsylvania-based manufacturer specializing in genomics-based diagnostic solutions for...

This is a $82,097.51 firm fixed price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Archerdx LLC, a subsidiary of Invitae Corporation. The contract is for CLONAL ARCHITECTURE OF TELOMERE DISEASES [22-014160] research, with a period of performance through August 10, 2023. Archerdx is a genomic analysis company that has previously received federal contracts from NIH and the Defense Health Agency to provide DNA...

The Defense Health Agency awarded a definitive firm fixed-price contract to Adaptive Biotechnologies Corporation valued at $681.3K for ClonoSEQ FDA-cleared in vitro diagnostic (IVD) testing services. The contract, awarded on March 14, 2025, runs through March 13, 2030, with performance taking place in San Antonio, Texas. This award represents an open competition with no set-aside designation and reflects the Defense Health Agency's procurement of specialized minimal residual disease testing...

This is a $85,500.00 firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business. The contract is for providing next-generation genomic sequence test services to support biomedical research efforts, with a focus on hematology-related research. The contract does not have a set-aside designation and is scheduled...